Research Focus

Dedicated innovation working group: Establishing a dedicated clinical and technology working group will help to identify, develop and implement innovative devices. This group will include clinical providers, engineers and scientists who will work together to develop, review and choose promising ideas to advance pediatric healthcare through new technologies and devices. The group will identify the priority pediatric diseases in greatest need of technological innovation; review new technologies that could be applied to healthcare; and explore the emerging field of omics technology to address pediatric disease.

Formal proposals process: Instituting a formal call for proposals process will help the PTC select, support, oversee and provide expertise to projects. This process will evaluate the intellectual property landscape, development costs, timeline and clinical impact to assess project proposals.

Product commercialization: Engaging industry experts will help to inform recommendations on commercialization of products. Leading experts in the field, serving as an external advisory board (EAB), will review this pillar’s current assets to make thoughtful recommendations for future projects, activities and resources for commercialization.

Launching successful products: Scaling successful strategies across Children’s and beyond will be possible through academic and industry collaborations. The EAB will identify steps for getting new technologies to market while working with investigators to verify necessary oversight and focus on the regulatory, quality and business components of device and technology development.

 

Objective

The PTC is poised to use its specialized knowledge and skill, structure and resources to drive pediatric technology and device innovation that will help make meaningful change in the quality of care we are able to provide to sick children and their families. We will strive to gain new knowledge in the care of
children and develop and apply novel lifesaving or life-enhancing technologies. New treatments, devices and diagnostic tools will go through testing, and, if successful, FDA approval and into clinical use. Ultimately, the research and innovation performed within this pillar will help patients at Children’s and beyond as leading-edge technologies and devices become accessible to pediatric care facilities at a national level.